Overview
Phase IIa Safety and Efficacy Study of SPP635 in Mild to Moderate Hypertension
Status:
Completed
Completed
Trial end date:
2007-05-01
2007-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is conducted to investigate the effect of the oral renin inhibitor SPP635 on blood pressure in patients with mild to moderate hypertension.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Speedel Pharma Ltd.
Criteria
Inclusion Criteria:- male or female patients with mild to moderate hypertension
Exclusion Criteria:
- female patients of child-bearing potential or breast-feeding